More important, I think, is that Brazil has a strong moral case and ACT-UP doesn't. Brazil is a poor country with lots of sick people who have no chance of finding anyone to pay first-world prices for drugs. The U.S. AIDS-afflicted population lives in the richest country in the world.
There is a strong argument that charging first-world prices for AIDS drugs in Brazil does nothing other than make more people die faster. There is an equally strong argument that if we want to see faster medical progress we shouldn't be in the business of trying to curb the profits pharmaceutical companies make in the first world...
Brad DeLong